Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 single and multiple ascending dose clinical study of TERN-501

X
Trial Profile

Phase 1 single and multiple ascending dose clinical study of TERN-501

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs TERN-501 (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Adverse reactions; First in man; Pharmacokinetics; Proof of concept
  • Sponsors Terns Pharmaceuticals
  • Most Recent Events

    • 08 Jun 2022 According to a Terns Pharmaceuticals media release, results from this trial were accepted for presentation at the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2022 and abstracts were published in the July supplement of the Journal of Hepatology.
    • 12 Nov 2021 According to a Terns Pharmaceuticals media release, data from this study was presented at The Liver Meeting Digital Experience 2021, the annual meeting of the American Association for the Study of Liver Diseases (AASLD)
    • 12 Nov 2021 Results published in Terns Pharmaceuticals Media Release
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top